LAPATINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 33 adverse event reports in the FDA FAERS database where LAPATINIB was used for Neoplasm malignant.
Most Reported Side Effects for LAPATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 382 | 19.3% | 35 | 131 |
| Disease progression | 227 | 11.5% | 37 | 21 |
| Palmar-plantar erythrodysaesthesia syndrome | 182 | 9.2% | 18 | 24 |
| Malignant neoplasm progression | 173 | 8.7% | 41 | 21 |
| Nausea | 161 | 8.1% | 17 | 67 |
| Metastases to central nervous system | 160 | 8.1% | 32 | 32 |
| Neutropenia | 160 | 8.1% | 11 | 27 |
| Vomiting | 155 | 7.8% | 16 | 67 |
| Asthenia | 148 | 7.5% | 19 | 38 |
| Fatigue | 139 | 7.0% | 13 | 50 |
| Off label use | 118 | 6.0% | 12 | 42 |
| Rash | 108 | 5.5% | 8 | 18 |
| Thrombocytopenia | 102 | 5.1% | 8 | 20 |
| Metastases to lymph nodes | 95 | 4.8% | 3 | 29 |
| Metastases to lung | 92 | 4.6% | 8 | 10 |
Other Indications for LAPATINIB
Breast cancer (447)
Breast cancer metastatic (434)
Her2 positive breast cancer (241)
Product used for unknown indication (233)
Her-2 positive breast cancer (151)
Invasive ductal breast carcinoma (113)
Breast cancer female (37)
Metastases to central nervous system (30)
Colorectal cancer metastatic (25)
Breast neoplasm (24)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)